Clinical Trial Update: Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating the effect of upfront radiosurgery on residual growth hormone-secreting pituitary adenoma (acromegaly). The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly Due to Pituitary Adenoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Acromegaly Due to Pituitary Adenoma | Phase 3 | Status: UNKNOWN